News

The latest developments in TMS research and treatment, curated by our team.

  • “Could Accelerated TMS for Depression Become Standard?”

    Transcranial magnetic stimulation (TMS) was first approved for the treatment of major depressive disorder (MDD) in 2008. Because it worked well for depression by using a strong magnetic field to stimulate key brain areas, TMS was recommended early on by the American Psychiatric Association in its 2010 Practice Guidelines (APA, 2010).

  • “Cognitive” Subtype of depression may be resistant to common drugs

    Scientists at Stanford Medicine conducted a study describing a new category of depression — labeled the cognitive biotype — which accounts for 27% of depressed patients and is not effectively treated by commonly prescribed antidepressants.

  • UBC Scientist Dr. Fidel Vila-Rodriguez describes TMS

    Dr. Fidel Vila-Rodriguez is a clinical scientist at the University of British Columbia’s NINET Lab studying repetitive transcranial magnetic stimulation (rTMS) in the treatment of depression, Parkinson’s disease, and OCD. In the second episode of the Capture Queue podcast, he explains what rTMS is, how it functions, and the work he’s doing to push for wider access to rTMS and similar treatments.

Information & education

Trusted, plain-language resources to help you and your family understand TMS and brain health.

Research Library

Peer-reviewed literature organized by condition, the evidence base behind everything we do.